{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,2]],"date-time":"2026-10-02T21:01:06Z","timestamp":1790974866158,"version":"4.1.0"},"reference-count":50,"publisher":"Public Library of Science (PLoS)","issue":"9","license":[{"start":{"date-parts":[[2013,9,2]],"date-time":"2013-09-02T00:00:00Z","timestamp":1378080000000},"content-version":"unspecified","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":["www.plosone.org"],"crossmark-restriction":false},"short-container-title":["PLoS ONE"],"DOI":"10.1371\/journal.pone.0072858","type":"journal-article","created":{"date-parts":[[2013,9,2]],"date-time":"2013-09-02T20:48:31Z","timestamp":1378154911000},"page":"e72858","update-policy":"https:\/\/doi.org\/10.1371\/journal.pone.corrections_policy","source":"Crossref","is-referenced-by-count":112,"title":["Effects of Lipid-Lowering Drugs on Irisin in Human Subjects In Vivo and in Human Skeletal Muscle Cells Ex Vivo"],"prefix":"10.1371","volume":"8","clinical-trial-number":[{"clinical-trial-number":"nct00317993","registry":"10.18810\/clinical-trials-gov"}],"author":[{"given":"Ioanna","family":"Gouni-Berthold","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Heiner K.","family":"Berthold","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Joo Young","family":"Huh","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Reena","family":"Berman","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nadine","family":"Spenrath","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Wilhelm","family":"Krone","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Christos S.","family":"Mantzoros","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"340","published-online":{"date-parts":[[2013,9,2]]},"reference":[{"key":"ref1","doi-asserted-by":"crossref","first-page":"1052","DOI":"10.1016\/j.metabol.2013.02.002","article-title":"Elevated skeletal muscle irisin precursor FNDC5 mRNA in obese OLETF rats","volume":"62","author":"MD Roberts","year":"2013","journal-title":"Metabolism"},{"key":"ref2","doi-asserted-by":"crossref","first-page":"1070","DOI":"10.1016\/j.metabol.2013.02.012","article-title":"Irisin levels correlate with energy expenditure in a subgroup of humans with energy expenditure greater than predicted by fat free mass","volume":"62","author":"AG Swick","year":"2013","journal-title":"Metabolism"},{"key":"ref3","doi-asserted-by":"crossref","first-page":"463","DOI":"10.1038\/nature10777","article-title":"A PGC1-alpha-dependent myokine that drives brown-fat-like development of white fat and thermogenesis","volume":"481","author":"P Bostrom","year":"2012","journal-title":"Nature"},{"key":"ref4","doi-asserted-by":"crossref","first-page":"1113","DOI":"10.1126\/science.1190816","article-title":"Medicine. Beige can be slimming","volume":"328","author":"J Ishibashi","year":"2010","journal-title":"Science"},{"key":"ref5","doi-asserted-by":"crossref","first-page":"7153","DOI":"10.1074\/jbc.M109.053942","article-title":"Chronic peroxisome proliferator-activated receptor gamma (PPARgamma) activation of epididymally derived white adipocyte cultures reveals a population of thermogenically competent, UCP1-containing adipocytes molecularly distinct from classic brown adipocytes","volume":"285","author":"N Petrovic","year":"2010","journal-title":"J Biol Chem"},{"key":"ref6","doi-asserted-by":"crossref","first-page":"293","DOI":"10.1242\/dmm.009894","article-title":"From white to brown fat through the PGC-1alpha-dependent myokine irisin: implications for diabetes and obesity","volume":"5","author":"JI Castillo-Quan","year":"2012","journal-title":"Dis Model Mech"},{"key":"ref7","doi-asserted-by":"crossref","first-page":"1725","DOI":"10.1016\/j.metabol.2012.09.002","article-title":"FNDC5 and irisin in humans: I. Predictors of circulating concentrations in serum and plasma and II. mRNA expression and circulating concentrations in response to weight loss and exercise","volume":"61","author":"JY Huh","year":"2012","journal-title":"Metabolism"},{"key":"ref8","doi-asserted-by":"crossref","first-page":"1267","DOI":"10.1016\/S0140-6736(05)67394-1","article-title":"Efficacy and safety of cholesterol-lowering treatment: prospective meta-analysis of data from 90,056 participants in 14 randomised trials of statins","volume":"366","author":"C Baigent","year":"2005","journal-title":"Lancet"},{"key":"ref9","doi-asserted-by":"crossref","first-page":"394","DOI":"10.1016\/S0140-6736(12)61426-3","article-title":"Interactive effects of fitness and statin treatment on mortality risk in veterans with dyslipidaemia: a cohort study","volume":"381","author":"PF Kokkinos","year":"2013","journal-title":"Lancet"},{"key":"ref10","doi-asserted-by":"crossref","first-page":"1633","DOI":"10.1093\/eurheartj\/ehq181","article-title":"Ezetimibe alone or in combination with simvastatin increases small dense low-density lipoproteins in healthy men: a randomized trial","volume":"31","author":"K Berneis","year":"2010","journal-title":"Eur Heart J"},{"key":"ref11","doi-asserted-by":"crossref","first-page":"262","DOI":"10.1055\/s-2007-993144","article-title":"SREBP-1c gene polymorphism is associated with increased inhibition of cholesterol-absorption in response to ezetimibe treatment","volume":"116","author":"HK Berthold","year":"2008","journal-title":"Exp Clin Endocrinol Diabetes"},{"key":"ref12","doi-asserted-by":"crossref","first-page":"198","DOI":"10.1016\/j.atherosclerosis.2007.09.034","article-title":"Effects of ezetimibe and\/or simvastatin on LDL receptor protein expression and on LDL receptor and HMG-CoA reductase gene expression: a randomized trial in healthy men","volume":"198","author":"I Gouni-Berthold","year":"2008","journal-title":"Atherosclerosis"},{"key":"ref13","doi-asserted-by":"crossref","first-page":"536","DOI":"10.1111\/j.1365-2265.2007.03080.x","article-title":"Short-term treatment with ezetimibe, simvastatin or their combination does not alter circulating adiponectin, resistin or leptin levels in healthy men","volume":"68","author":"I Gouni-Berthold","year":"2008","journal-title":"Clin Endocrinol (Oxf)"},{"key":"ref14","doi-asserted-by":"crossref","first-page":"703","DOI":"10.2165\/00002018-200629080-00007","article-title":"Effect of ezetimibe and\/or simvastatin on coenzyme Q10 levels in plasma: a randomised trial","volume":"29","author":"HK Berthold","year":"2006","journal-title":"Drug Saf"},{"key":"ref15","doi-asserted-by":"crossref","first-page":"49","DOI":"10.1111\/j.1365-2265.2006.02684.x","article-title":"Short-term fasting-induced autonomic activation and changes in catecholamine levels are not mediated by changes in leptin levels in healthy humans","volume":"66","author":"JL Chan","year":"2007","journal-title":"Clin Endocrinol (Oxf)"},{"key":"ref16","doi-asserted-by":"crossref","first-page":"4542","DOI":"10.1210\/jc.2005-0372","article-title":"Circulating adiponectin levels are associated with better glycemic control, more favorable lipid profile, and reduced inflammation in women with type 2 diabetes","volume":"90","author":"CS Mantzoros","year":"2005","journal-title":"J Clin Endocrinol Metab"},{"key":"ref17","doi-asserted-by":"crossref","first-page":"2450","DOI":"10.2337\/diacare.27.10.2450","article-title":"Circulating adiponectin and resistin levels in relation to metabolic factors, inflammatory markers, and vascular reactivity in diabetic patients and subjects at risk for diabetes","volume":"27","author":"GK Shetty","year":"2004","journal-title":"Diabetes Care"},{"key":"ref18","doi-asserted-by":"crossref","first-page":"280","DOI":"10.2337\/dc06-1362","article-title":"Total and high-molecular weight adiponectin in relation to metabolic variables at baseline and in response to an exercise treatment program: comparative evaluation of three assays","volume":"30","author":"M Bluher","year":"2007","journal-title":"Diabetes Care"},{"key":"ref19","doi-asserted-by":"crossref","first-page":"198","DOI":"10.1016\/j.freeradbiomed.2011.10.449","article-title":"Simvastatin impairs ADP-stimulated respiration and increases mitochondrial oxidative stress in primary human skeletal myotubes","volume":"52","author":"HB Kwak","year":"2012","journal-title":"Free Radic Biol Med"},{"key":"ref20","doi-asserted-by":"crossref","first-page":"67","DOI":"10.1097\/BOR.0b013e328010c559","article-title":"Myotoxicity associated with lipid-lowering drugs","volume":"19","author":"AN Baer","year":"2007","journal-title":"Curr Opin Rheumatol"},{"key":"ref21","doi-asserted-by":"crossref","first-page":"III50","DOI":"10.1161\/01.CIR.0000131519.15067.1f","article-title":"Safety of statins: focus on clinical pharmacokinetics and drug interactions","volume":"109","author":"S Bellosta","year":"2004","journal-title":"Circulation"},{"key":"ref22","doi-asserted-by":"crossref","first-page":"2844","DOI":"10.1096\/fj.08-128843","article-title":"Statin-induced muscle damage and atrogin-1 induction is the result of a geranylgeranylation defect","volume":"23","author":"P Cao","year":"2009","journal-title":"FASEB J"},{"key":"ref23","doi-asserted-by":"crossref","first-page":"325","DOI":"10.1007\/s00424-010-0919-9","article-title":"The role and regulation of MAFbx\/atrogin-1 and MuRF1 in skeletal muscle atrophy","volume":"461","author":"VC Foletta","year":"2011","journal-title":"Pflugers Arch"},{"key":"ref24","doi-asserted-by":"crossref","first-page":"2844","DOI":"10.1096\/fj.08-128843","article-title":"Statin-induced muscle damage and atrogin-1 induction is the result of a geranylgeranylation defect","volume":"23","author":"P Cao","year":"2009","journal-title":"FASEB J"},{"key":"ref25","doi-asserted-by":"crossref","first-page":"330","DOI":"10.1016\/j.atherosclerosis.2008.10.005","article-title":"The effects of ezetimibe on LDL-cholesterol: quantitative or qualitative changes?","volume":"204","author":"M Rizzo","year":"2009","journal-title":"Atherosclerosis"},{"key":"ref26","doi-asserted-by":"crossref","first-page":"1985","DOI":"10.1517\/14656566.2012.720974","article-title":"Clinical benefits of ezetimibe use: is absence of proof, proof of absence?","volume":"13","author":"I Gouni-Berthold","year":"2012","journal-title":"Expert Opin Pharmacother"},{"key":"ref27","doi-asserted-by":"crossref","first-page":"317","DOI":"10.1016\/j.ejim.2012.01.004","article-title":"Statin induced myotoxicity","volume":"23","author":"S Sathasivam","year":"2012","journal-title":"Eur J Intern Med"},{"key":"ref28","doi-asserted-by":"crossref","first-page":"1397","DOI":"10.1093\/eurheartj\/ehr224","article-title":"Opposite effects of statins on mitochondria of cardiac and skeletal muscles: a &apos;mitohormesis&apos; mechanism involving reactive oxygen species and PGC-1","volume":"33","author":"J Bouitbir","year":"2012","journal-title":"Eur Heart J"},{"key":"ref29","doi-asserted-by":"crossref","first-page":"169","DOI":"10.1016\/j.ijcard.2011.07.048","article-title":"Managing the underestimated risk of statin-associated myopathy","volume":"159","author":"LS Rallidis","year":"2012","journal-title":"Int J Cardiol"},{"key":"ref30","doi-asserted-by":"crossref","first-page":"2015","DOI":"10.1210\/jc.2009-2689","article-title":"Approach to the patient who is intolerant of statin therapy","volume":"95","author":"RH Eckel","year":"2010","journal-title":"J Clin Endocrinol Metab"},{"key":"ref31","doi-asserted-by":"crossref","first-page":"281","DOI":"10.1016\/j.taap.2012.06.020","article-title":"Effect of a high dose of simvastatin on muscle mitochondrial metabolism and calcium signaling in healthy volunteers","volume":"263","author":"F Galtier","year":"2012","journal-title":"Toxicol Appl Pharmacol"},{"key":"ref32","doi-asserted-by":"crossref","unstructured":"Mikus CR, Boyle LJ, Borengasser SJ, Oberlin DJ, Naples SP, <etal>et al<\/etal>.. (2013) Simvastatin impairs exercise training adaptations. J Am Coll Cardiol.","DOI":"10.1016\/j.jacc.2013.02.074"},{"key":"ref33","doi-asserted-by":"crossref","first-page":"1670","DOI":"10.1016\/S0140-6736(10)61350-5","article-title":"Efficacy and safety of more intensive lowering of LDL cholesterol: a meta-analysis of data from 170,000 participants in 26 randomised trials","volume":"376","author":"C Baigent","year":"2010","journal-title":"Lancet"},{"key":"ref34","doi-asserted-by":"crossref","first-page":"89","DOI":"10.1146\/annurev.pharmtox.45.120403.095748","article-title":"Pleiotropic effects of statins","volume":"45","author":"JK Liao","year":"2005","journal-title":"Annu Rev Pharmacol Toxicol"},{"key":"ref35","doi-asserted-by":"crossref","first-page":"42","DOI":"10.1126\/science.1221688","article-title":"Medicine. Irisin, light my fire","volume":"336","author":"DP Kelly","year":"2012","journal-title":"Science"},{"key":"ref36","doi-asserted-by":"crossref","first-page":"708","DOI":"10.1111\/j.1464-5491.2009.02747.x","article-title":"The effect of anti-inflammatory (aspirin and\/or statin) therapy on body weight in Type 2 diabetic individuals: EAT, a retrospective study","volume":"26","author":"M Boaz","year":"2009","journal-title":"Diabet Med"},{"key":"ref37","doi-asserted-by":"crossref","first-page":"758","DOI":"10.4065\/83.7.758","article-title":"Simvastatin vs therapeutic lifestyle changes and supplements: randomized primary prevention trial","volume":"83","author":"DJ Becker","year":"2008","journal-title":"Mayo Clin Proc"},{"key":"ref38","doi-asserted-by":"crossref","first-page":"1032","DOI":"10.2337\/db12-1612","article-title":"Mitochondrial deficiency is associated with insulin resistance","volume":"62","author":"BH Goodpaster","year":"2013","journal-title":"Diabetes"},{"key":"ref39","doi-asserted-by":"crossref","unstructured":"Liu JJ, Wong MD, Toy WC, Tan CS, Liu S, <etal>et al<\/etal>.. (2013) Lower circulating irisin is associated with type 2 diabetes mellitus. J Diabetes Complications.","DOI":"10.1016\/j.jdiacomp.2013.03.002"},{"key":"ref40","doi-asserted-by":"crossref","first-page":"E769","DOI":"10.1210\/jc.2012-2749","article-title":"Irisin is expressed and produced by human muscle and adipose tissue in association with obesity and insulin resistance","volume":"98","author":"JM Moreno-Navarrete","year":"2013","journal-title":"J Clin Endocrinol Metab"},{"key":"ref41","doi-asserted-by":"crossref","first-page":"964","DOI":"10.1016\/j.bbalip.2012.03.004","article-title":"Niemann-Pick C1-Like 1 and cholesterol uptake","volume":"1821","author":"LJ Wang","year":"2012","journal-title":"Biochim Biophys Acta"},{"key":"ref42","doi-asserted-by":"crossref","first-page":"2253","DOI":"10.1194\/jlr.E031823","article-title":"Physiological role of hepatic NPC1L1 in human cholesterol and lipoprotein metabolism: New perspectives and open questions","volume":"53","author":"PN Howles","year":"2012","journal-title":"J Lipid Res"},{"key":"ref43","doi-asserted-by":"crossref","first-page":"G776","DOI":"10.1152\/ajpgi.90275.2008","article-title":"Reduced absorption of saturated fatty acids and resistance to diet-induced obesity and diabetes by ezetimibe-treated and Npc1l1-\/- mice","volume":"295","author":"ED Labonte","year":"2008","journal-title":"Am J Physiol Gastrointest Liver Physiol"},{"key":"ref44","doi-asserted-by":"crossref","first-page":"7213","DOI":"10.1074\/jbc.M111.286724","article-title":"Low density lipoprotein (LDL) receptor-related protein 6 (LRP6) regulates body fat and glucose homeostasis by modulating nutrient sensing pathways and mitochondrial energy expenditure","volume":"287","author":"W Liu","year":"2012","journal-title":"J Biol Chem"},{"key":"ref45","doi-asserted-by":"crossref","first-page":"406","DOI":"10.3858\/emm.2009.41.6.046","article-title":"Sterol-independent repression of low density lipoprotein receptor promoter by peroxisome proliferator activated receptor gamma coactivator-1alpha (PGC-1alpha)","volume":"41","author":"JH Jeong","year":"2009","journal-title":"Exp Mol Med"},{"key":"ref46","doi-asserted-by":"crossref","first-page":"405","DOI":"10.1007\/s11095-010-0294-4","article-title":"Human NPC1L1 expression is positively regulated by PPARalpha","volume":"28","author":"Y Iwayanagi","year":"2011","journal-title":"Pharm Res"},{"key":"ref47","doi-asserted-by":"crossref","unstructured":"Danaei G, Rodriguez LA, Cantero OF, Hernan MA (2012) Statins and Risk of Diabetes: An analysis of electronic medical records to evaluate possible bias due to differential survival. Diabetes Care.","DOI":"10.2337\/dc12-1756"},{"key":"ref48","doi-asserted-by":"crossref","first-page":"299","DOI":"10.1007\/s11883-012-0299-z","article-title":"Statins and diabetes: the good, the bad, and the unknown","volume":"15","author":"K Axsom","year":"2013","journal-title":"Curr Atheroscler Rep"},{"key":"ref49","doi-asserted-by":"crossref","unstructured":"Choi YK, Kim MK, Bae KH, Seo HA, Jeong JY, <etal>et al<\/etal>.. (2013) Serum irisin levels in new-onset type 2 diabetes. Diabetes Res Clin Pract.","DOI":"10.1016\/j.diabres.2013.01.007"},{"key":"ref50","doi-asserted-by":"crossref","first-page":"293","DOI":"10.1242\/dmm.009894","article-title":"From white to brown fat through the PGC-1alpha-dependent myokine irisin: implications for diabetes and obesity","volume":"5","author":"JI Castillo-Quan","year":"2012","journal-title":"Dis Model Mech"}],"container-title":["PLoS ONE"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/dx.plos.org\/10.1371\/journal.pone.0072858","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,5,17]],"date-time":"2024-05-17T15:09:38Z","timestamp":1715958578000},"score":1,"resource":{"primary":{"URL":"https:\/\/dx.plos.org\/10.1371\/journal.pone.0072858"}},"subtitle":[],"editor":[{"given":"Raul M.","family":"Luque","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"editor"}]}],"short-title":[],"issued":{"date-parts":[[2013,9,2]]},"references-count":50,"journal-issue":{"issue":"9","published-online":{"date-parts":[[2013,9,2]]}},"URL":"https:\/\/doi.org\/10.1371\/journal.pone.0072858","relation":{},"ISSN":["1932-6203"],"issn-type":[{"value":"1932-6203","type":"electronic"}],"subject":[],"published":{"date-parts":[[2013,9,2]]}}}